RevBio
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
600 Suffolk St Ste 250, Lowell, Massachu...Phone Number
(617) 460-6675Website
www.revbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About RevBio
For RevBio, the revolution started here, in Massachusetts. It also started in nature with bio-inspiration from an amazing marine animal known as the Sandcastle Worm. Headquartered in Lowell, the company includes an extensive team of scientists, engineers, and clinicians who have reverse engineered a mineral-organic compound into a patented bioadhesive with an extensive platform of bone repair applications. A MassChallenge start-up accelerator alum, RevBio has won over 10 grants, received multiple patents, and is conducting its first-in-human clinical trial on its biomimetic bone adhesive.Explore more
RevBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RevBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at RevBio
Funding: Get notified immidiatlly once RevBio has new funding data
Click to see if RevBio had a recent Job posting/layoffs
Check out if RevBio is spiking on competitors!
Earning: See what the market has to say on RevBio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if RevBio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when RevBio launches new products
RevBio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at RevBio
Find 2 more new buyers
Compare Similar Companies to RevBio
Compare insights from companies similar to RevBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RevBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RevBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RevBio.
RevBio financials insights
Gather financial insights about RevBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$10M
RevBio Tech Stack
A closer look at the technologies used by RevBio
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
, according to a recent Form D filing, has secured $10,023,457 in Debt funding.
Funding
Project
Product Management, Intellectual Property, Legal Affairs, Governmental Affairs & Regulation, Regulations
Project
Research & Development, Product Management, Governmental Affairs & Regulation, Medical Research, Clinical Operations, Regulations
Funding
Project
Product Development, Safety, Clinical Operations, Operations
RevBio News & Media
RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
LOWELL, Mass.--(BUSINESS WIRE)-- #BoneRepair--RevBio, Inc., announced that it has received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal clinical trial for its dental implant stabilization product. The successful completion of this pivotal clinical trial will result in the CE marking approval for the product, which will allow the company to begin commercial sales in Europe. As of the date of this press release, the company has already enrolled 30RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
LOWELL, Mass.--(BUSINESS WIRE)-- #BoneRepair--The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for Adhesion to Surfaces,” which constitutes the 10th U.S. patent that covers the TETRANITE bone adhesive technology. This patent expands the protected technology to include injectable mineral-organic structural bone adhesive compositions that comprise alpha tricalcium phosphate. The issuance of this patent complements RevBio’s existingRevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation
LOWELL, Mass.--(BUSINESS WIRE)-- #BoneRepair--RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap FixationRevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients
LOWELL, Mass.--(BUSINESS WIRE)-- #BoneRepair--RevBio, Inc., announced that it has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disease and Stroke (NINDS), part of the National Institutes of Health (NIH). This two-year grant (1R44NS135736-01A1) will allow the company to complete a 20-patient pilot clinical trial to examine the safety and efficacy of the company’s bone adhesive biomaterial called TETRANITE® which w
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding RevBio
Sign Up For FreeTo access detailed company insights
For RevBio, the revolution started here, in Massachusetts. It also started in nature with bio-inspiration from an amazing marine animal known as the Sandcastle Worm. Headquartered in Lowell, the company includes an extensive team of scientists, engineers, and clinicians who have reverse engineered a mineral-organic compound into a patented bioadhes... Read More
